Armistice Capital, LLC Immunocore Holdings PLC Transaction History
Armistice Capital, LLC
- $5.71 Billion
- Q2 2025
A detailed history of Armistice Capital, LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Armistice Capital, LLC holds 678,000 shares of IMCR stock, worth $21.6 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
678,000
Previous 978,000
30.67%
Holding current value
$21.6 Million
Previous $29 Million
26.68%
% of portfolio
0.37%
Previous 0.44%
Shares
14 transactions
Others Institutions Holding IMCR
# of Institutions
145Shares Held
45.1MCall Options Held
297KPut Options Held
1.17M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.07MShares$225 Million0.14% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$155 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$134 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$120 Million0.1% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$77.8 Million1.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.4B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...